Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 or Rs 3,548 a year in more than 100 countries from 2027, Unitaid and the Gates Foundation said Wednesday.
HIV-Prevention Drug To Be Available For Rs 3,500 A Year From 2027
